TGA Approval

ORENCIA abatacept (rch) 250 mg powder for IV infusion vial (130100)

ARTG ID

130100

ARTG Name

ORENCIA abatacept (rch) 250 mg powder for IV infusion vial

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

September 27, 2007

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/fa39a9328c2386ba0f85868924ffb045.pdf

https://medical-cdn.nocode.com/drug_tga/53dede8ca34c80c29fe90c422fcf2d8b.pdf

Ingredient Name

Abatacept

Empowering clinical research with data-driven insights and AI-powered tools.

ORENCIA abatacept (rch) 250 mg powder for IV infusion vial (130100) - TGA 批准文号 | MedPath